By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pierre Fabre 

Centre d'Immunologie Pierre FABRE
5, avenue Napolean III - BP 497
St. Julien en Genevois Cedex    74164  France
Phone: 33-4-50-35-35-55 Fax: 33-4-50-35-35-90




Merck & Co.  Cancer

Company News
Pierre Fabre And H-Immune Announce Strategic Research Partnership To Develop Potentially Ground-Breaking Cancer Immunotherapies 3/21/2017 6:51:58 AM
Pierre Fabre And Hill Dermaceuticals Announce A Strategic Commercial Partnership For TOLAK (Fluorouracil) Cream 4% In The USA And Beyond 3/6/2017 10:46:36 AM
PIQUR Release: Pharma And Pierre Fabre Announce Partnership In Dermato-Oncology 1/11/2017 10:06:29 AM
Pierre Fabre And Array BioPharma (ARRY) Release: COLUMBUS Phase 3 Study Results In BRAF-Mutant Melanoma Presented At Society For Melanoma Research Annual Congress 11/9/2016 10:27:43 AM
Array BioPharma (ARRY), Pierre Fabre And Merck KGaA (MKGAF.PK), Darmstadt, Germany Announce Phase 3 BEACON CRC Trial 6/6/2016 10:58:54 AM
Merck & Co. (MRK) Partners With Array BioPharma (ARRY) And Pierre Fabre To Initiate BRAF-Mutant CRC Phase III Trial 6/6/2016 9:59:43 AM
Evotec AG (EVTG.F) And Pierre Fabre Sign Multi-Year Compound Management Agreement 4/19/2016 12:55:08 PM
Pierre Fabre Sign A New Partnership With A Biotech Company From The Toulouse Region, Vibiosphen, Within The Framework Of The Open Innovation Program "Nature Open Library" 4/14/2016 10:35:27 AM
Plasticell And Pierre Fabre Sign A Partnership To Identify Natural Stimulants Of Brown Fat For Treatment And Prevention Of Obesity And Diabetes 2/23/2016 2:14:45 PM
"Pierre Fabre Fund For Innovation" To Present At The 4th Annual Sachs Cancer Bio Partnering & Investment Forum 2/19/2016 8:56:52 AM